AMZN
Amazon.com, Inc.
AMZN has the edge over LCII overall, supported by stronger modeled upside and lower modeled downside.
LCII
LCI Industries
LCII trails on the overall score without a compensating advantage in the available component scores.
AMZN Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Healthy | |
| Weak | |
| Healthy |
AMZN's revenue, profitability and balance sheet are currently healthy, but its cash flow is weak.
LCII Fundamentals
| Metric | Status |
|---|---|
| Under pressure | |
| Healthy | |
| Stable | |
| Healthy |
LCII's profitability and balance sheet are currently healthy, and its cash flow is stable, but its revenue is under pressure.
AMZN PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Current | 22x | $267 | — |
| Forward | 27x | $267 | — |
| Cheap | 34x | $415 | +55% |
| Fair | 60x | $745 | +179% |
| Expensive | 102x | $1,262 | +372% |
Historical ranges are pointers, not guarantees.
AMZN has the edge over LCII in the historical PE scenario, which offers more potential upside but is not a forecast.
LCII PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 9.6x | $78.22 | -19% |
| Current | 12x | $96.99 | — |
| Fair | 16x | $132 | +36% |
| Expensive | 26x | $212 | +119% |
Historical ranges are pointers, not guarantees.
LCII's PE is in its cheap range at 12x.
AMZN Forward outlook
| Metric | Outlook |
|---|---|
| Strongly deteriorating | |
| Strong growth | |
| Growth | |
| Improving | |
| Moderate | |
| Moderate |
Analysts expect earnings and revenue growth for AMZN, with profitability improving.
LCII Forward outlook
There aren't enough analyst estimates for LCII to show an outlook.
AMZN Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $9.87 | -20% |
| Q3 2026 | $12.37 | +75% |
| Q2 2026 | $12.43 | +89% |
| Q1 2026 | $8.36 | +36% |
| Q4 2025 | $7.17 | +30% |
| Q3 2025 | $7.08 | +52% |
| Q2 2025 | $6.56 | +57% |
| Q1 2025 | $6.14 | +72% |
| Q4 2024 | $5.53 | +91% |
AMZN has the edge over LCII on earnings, with stronger typical year-over-year growth.
LCII Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2026 | $8.12 | +14% |
| Q2 2026 | $8.62 | +44% |
| Q1 2026 | $8.16 | +34% |
| Q4 2025 | $7.57 | +35% |
| Q3 2025 | $7.15 | +39% |
| Q2 2025 | $5.99 | +26% |
| Q1 2025 | $6.10 | +66% |
| Q4 2024 | $5.60 | +122% |
LCII's earnings per share have fallen from their peak: $8.12 over the past year, against $19.49 in mid-2022.
AMZN Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $201.9B | +12% |
| Q2 2026 | $200.6B | +20% |
| Q1 2026 | $181.5B | +17% |
| Q4 2025 | $213.4B | +14% |
| Q3 2025 | $180.2B | +13% |
| Q2 2025 | $167.7B | +13% |
| Q1 2025 | $155.7B | +8.6% |
| Q4 2024 | $187.8B | +10% |
AMZN has the edge over LCII on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 14% | +4.2 points |
| Q2 2026 | 14% | +2.3 points |
| Q1 2026 | 13% | +1.3 points |
| Q4 2025 | 12% | +0.4 points |
| Q3 2025 | 9.7% | -1.3 points |
| Q2 2025 | 11% | +1.5 points |
| Q1 2025 | 12% | +1.1 points |
| Q4 2024 | 11% | +3.5 points |
AMZN has the edge over LCII on profitability, with a higher operating margin.
LCII Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $992.5M | -4.2% |
| Q2 2026 | $968.7M | -13% |
| Q1 2026 | $1.1B | +4.3% |
| Q4 2025 | $932.7M | +16% |
| Q3 2025 | $1B | +13% |
| Q2 2025 | $1.1B | +5% |
| Q1 2025 | $1B | +8% |
| Q4 2024 | $803.1M | -4.1% |
LCII's revenue fell from its 2022 peak and has held roughly level since: $992M last quarter, down 4.2% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 7.6% | +0.3 points |
| Q2 2026 | 9.9% | +2 points |
| Q1 2026 | 8.7% | +1 points |
| Q4 2025 | 3.8% | +1.8 points |
| Q3 2025 | 7.3% | +1.4 points |
| Q2 2025 | 7.9% | -0.7 points |
| Q1 2025 | 7.8% | +1.8 points |
| Q4 2024 | 2% | +1.7 points |
LCII's operating margin was 7.6% last quarter, about level with the same quarter a year ago.
AMZN Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$34.8B | -8202% |
| Q2 2026 | -$8.8B | -2757% |
| Q1 2026 | -$18.2B | -$10.2B |
| Q4 2025 | $14.9B | -16% |
| Q3 2025 | $430M | -87% |
| Q2 2025 | $332M | -96% |
| Q1 2025 | -$8B | -297% |
| Q4 2024 | $17.8B | -36% |
AMZN's free cash flow was −$46.9B over the past year, against $10.6B the year before.
LCII Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $53.6M | -34% |
| Q2 2026 | $184.9M | +86% |
| Q1 2026 | -$43.1M | -228% |
| Q4 2025 | $64.3M | -33% |
| Q3 2025 | $80.9M | +18% |
| Q2 2025 | $99.5M | -45% |
| Q1 2025 | $33.7M | +$49.9M |
| Q4 2024 | $95.7M | -24% |
LCII has the edge over AMZN on cash generation, producing positive trailing cash flow while its opponent burns cash.
AMZN Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +0.2% | +26M shares |
| 1 year | +0.8% | +84M shares |
| 3 years | +3.5% | +371M shares |
| 5 years | +6.1% | +629M shares |
| Available history | +8.2% | +829M shares |
AMZN has 10.9B diluted shares, up 0.8% from a year ago.
| Quarter | Spent |
|---|---|
| Q1 2024 | — |
| Q4 2023 | — |
| Q3 2023 | — |
| Q2 2023 | — |
| Q1 2023 | — |
| Q4 2022 | — |
| Q3 2022 | — |
| Q2 2022 | $3.3B |
LCII Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +0.1% | +25K shares |
| 1 year | -0.2% | -49K shares |
| 3 years | -4.3% | -1.1M shares |
| 5 years | -3.9% | -1M shares |
| Available history | -2.7% | -676K shares |
LCII has the edge over AMZN on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q3 2026 | — |
| Q2 2026 | — |
| Q1 2026 | — |
| Q4 2025 | — |
| Q3 2025 | $62.2M |
| Q2 2025 | $38.1M |
| Q1 2025 | $28.3M |
LCII hasn't bought back shares in the past year.
AMZN Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 0.7x | Very low |
| Q2 2026 | 0.3x | Very low |
| Q1 2026 | 0.1x | Very low |
| Q4 2025 | -0.1x | Net Cash |
| Q3 2025 | -0.1x | Net Cash |
| Q2 2025 | -0.0x | Net Cash |
| Q1 2025 | -0.1x | Net Cash |
| Q4 2024 | -0.2x | Net Cash |
AMZN has the edge over LCII on leverage, with a lower net debt burden relative to earnings.
LCII Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 1.4x | Healthy |
| Q2 2026 | 1.5x | Healthy |
| Q1 2026 | 1.9x | Healthy |
| Q4 2025 | 1.8x | Healthy |
| Q3 2025 | 2.0x | Healthy |
| Q2 2025 | 2.1x | Moderate |
| Q1 2025 | 1.9x | Healthy |
| Q4 2024 | 1.7x | Healthy |
LCII's net debt is about 1.4 years of its operating earnings (EBITDA), down from 2.0 years a year ago.
AMZN Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 57.1 | Neutral |
| Stochastic | 50.0 | Neutral |
AMZN's weekly RSI is 57 (neutral) and its Stochastic is 50 (neutral).
LCII Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 48.6 | Neutral |
| Stochastic | 63.9 | Neutral |
LCII's weekly RSI is 49 (neutral) and its Stochastic is 64 (neutral).
AMZN PE vs Consumer Cyclical Sector
| Metric | AMZN | Sector median | Relative |
|---|---|---|---|
| PE | 22x | 18x | 20% above |
| PE % | 4 | 47 | 43 pts below |
AMZN is trading at 22x earnings, a 20% premium to the Consumer Cyclical sector's median of 18x, though its recent earnings include one-off gains.
LCII PE vs Consumer Cyclical Sector
| Metric | LCII | Sector median | Relative |
|---|---|---|---|
| PE | 12x | 18x | 34% below |
| PE % | 23 | 47 | 24 pts below |
LCII has the edge over AMZN on valuation relative to its sector.
AMZN Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $253.6 | 5.5% above |
| 20 week MA | $254.9 | 4.9% above |
| 50 week MA | $242.5 | 10% above |
| 100 week MA | $229.6 | 17% above |
| 200 week MA | $191.4 | 40% above |
AMZN has the edge over LCII on trend strength, trading above more of its moving averages.
LCII Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $88.5 | 9.6% above |
| 20 week MA | $96.3 | 0.7% above |
| 50 week MA | $112.3 | 14% below |
| 100 week MA | $104.4 | 7.1% below |
| 200 week MA | $109.8 | 12% below |
LCII has bounced recently, but its long-term trend is still down: it's above its 8- and 20-week averages, but 12% below its 200-week average.
AMZN Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $93.5 | $158.6 | +70% |
| 2021 | $158.6 | $171.1 | +7.8% |
| 2022 | $171.1 | $85.3 | -50% |
| 2023 | $85.3 | $151.9 | +78% |
| 2024 | $151.9 | $223.8 | +47% |
| 2025 | $223.8 | $232.5 | +3.9% |
| 2026 YTD | $232.5 | $267.4 | +15% |
AMZN has the edge over LCII on returns for 2026, with the stronger performance.
LCII Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $108.7 | $134.3 | +24% |
| 2021 | $134.3 | $149.9 | +12% |
| 2022 | $149.9 | $94.8 | -37% |
| 2023 | $94.8 | $125.7 | +33% |
| 2024 | $125.7 | $102.7 | -18% |
| 2025 | $102.7 | $123.7 | +20% |
| 2026 YTD | $123.7 | $97.0 | -22% |
LCII has finished higher in four of the last six years. It's down 22% so far in 2026.